At a glance
What MOTS-c actually is
MOTS-c is a peptide: a short chain of amino acids, the pieces that form proteins.
Your body makes MOTS-c, and researchers have found it in blood and muscle.
The instructions for making MOTS-c are in mitochondria, the parts of your cells that help produce energy.
The approval brief
Can a pharmacy make MOTS-c for me?
Compounding means having a pharmacist or doctor make medicine to order for a patient instead of using a ready-made product.
As of September 2026, MOTS-c fails the federal ingredient rules for a pharmacy making medicine to order for a named patient.
A doctor’s prescription does not remove those ingredient limits.
As of September 30, 2026, FDA’s list of withdrawn requests includes the request to allow MOTS-c in pharmacy-made medicines.
Here, “withdrawn” means the people who submitted the request took it back.
Taking the request back does not give a pharmacy permission to make MOTS-c medicines.
Your state’s pharmacy board is the public body that gives pharmacies permission to operate.
If a clinic claims an exception, ask for it in writing and have your state’s pharmacy board check it before agreeing to treatment.
The evidence brief
What the research can tell you
Mice are a starting point
In Lee’s mouse study, published in 2015, treated mice gained less weight and handled sugar better on a high-fat diet.
The mouse results do not show that MOTS-c helps people.
Measuring the MOTS-c already in someone’s blood is different from testing a MOTS-c treatment.
The finished study tested a changed version
A completed human study listed on ClinicalTrials.gov tested CB4211, a substance made by changing MOTS-c.
The company developing CB4211 reported its own findings; they had not appeared in a medical journal as of September 30, 2026.
CB4211 is different from MOTS-c itself, so that study cannot tell you how a MOTS-c shot would work.
A MOTS-c study has no results yet
A public study entry describes a MOTS-c study in adults with extra weight that began in February 2026.
As of September 30, 2026, that entry said the study was still inviting people to join and had no results posted.
The safety brief
The gaps in safety knowledge
FDA’s MOTS-c review found no human studies showing whether MOTS-c is safe.
FDA also found no animal tests for damage to genes (the instructions inside cells), harm during pregnancy or cancer risk.
That is missing information, not evidence that MOTS-c causes those harms.
FDA raises a concern that injected MOTS-c could trigger an immune reaction, meaning the body’s defences treat it as an invader.
This is a possible risk; studies have not shown how often it might happen in people.
The care brief
Start with your concern, then check the clinician
The word clinician means a health professional who evaluates people and provides treatment.
A care discussion can happen at a clinic in person or through telehealth, using video, phone calls or exchanges online.
Lead with what is bothering you: weight changes, blood sugar or energy. Ask which tests or established treatments fit that concern.
Be ready to discuss options beyond MOTS-c.
- Write down what changed, when it began and what you hope to improve.
- Bring a list naming each medicine and supplement you take.
- Add questions about pregnancy, breastfeeding or past reactions.
Check the person
Ask for the clinician's full name and licence details.
State medical boards give doctors permission to practise and publish whether a doctor’s licence is current.
They also publish public records of action taken against doctors for breaking professional rules.
Open the board for your state through the medical board directory, then search the doctor’s name.
As of September 2026, US health department guidance says online clinicians need permission to practise in the state you are physically in during your visit.
If the clinician claims an exception, ask your state’s medical board to check it.
A current licence does not tell you how skilled a doctor is.
Check the pharmacy too
If medicine is proposed, ask who would make and supply it.
FDA’s pharmacy lookup sends you to your state’s licence records.
A pharmacy licence means the business has permission to operate; it does not show that every product it supplies is appropriate.
Keep the pharmacy's name with your care notes.
The risk brief
Claims that deserve a pause
The cost brief
What it costs—and what to get in writing
As of September 30, 2026, no FDA-approved MOTS-c medicine exists, so there is no published price from an approved product’s maker.
This guide has no reliable price range for MOTS-c care.
A price in an advertisement does not show that MOTS-c is approved, works in people or meets pharmacy ingredient rules.
Ask for the full bill in writing before agreeing to care: the visit, tests, any medicine and later visits. For a monthly plan, ask for the total over its full length.
- The visit
- Is the fee paid once, or every month? Will I pay for the visit even if I decide against treatment?
- Tests
- Which tests do I need and why? Will I pay the lab separately?
- Follow-up
- What is included, and what creates another charge?
- Any proposed medicine
- Which medicine is proposed? Who will make it, and what does it add to the bill?
Keep this bit
Take these questions to a care visit
- Which health concern are we trying to address?
- What evidence in people supports this option for that problem?
- Is this a medicine with FDA approval or one made to order? Does the label instead say “for research use only”?
- Will you name the product and pharmacy in writing so I can ask my state’s pharmacy board to check the offer?
- Which clinician and pharmacy can I check in public licence records?
- What will the visit, tests and follow-up cost, including if treatment is declined?
- How can I reach the clinician with questions after the visit?
A useful answer names the evidence, the limits and the next step. You do not have to settle the whole decision today.
The word brief
Care words, in plain language
- Peptide
- A short chain of amino acids, the pieces that form proteins.
- Compounding
- Preparing medicine for a patient’s particular needs instead of supplying a ready-made product.
- Telehealth
- Care through video, phone calls or exchanges online.
- Clinical trial
- A study that tests a treatment in people.